LoginRegister

    Zydus Cadila gets USFDA nod to market alcohol abstinence drug

    Written by Ruby Khatun Khatun   |  

    New Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Acamprosate calcium delayed-release tablets used for maintenance of abstinence from alcohol in the US market.


    "Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Acamprosate calcium delayed-release tablets, 333 mg", Cadila Healthcare said in a BSE filing.


    The drug will be produced at the groups formulations manufacturing facility at Baddi, it added.



    "This medication is used for maintenance of abstinence from alcohol in patients with alcohol dependence", Cadila Healthcare said.

    The group now has more than 115 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since the commencement of the filing process in financial year 2003 -04, it added.

    abbreviated new drug applicationsAcamprosate calcium delayed-release tabletsalcohol abstinence drugapprovalCadila Healthcareindian pharma newspharma newspharma news indiaUSFDAZydus Cadila
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X